Squamous cell carcinoma antigen serum levels as prognostic parameter in patients with early stage vulvar cancer
Authors:
- 1 June 2005
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 97 (3) , 904-907
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Measurement of serum squamous cell carcinoma antigen levels as a predictor of radiation response in patients with carcinoma of the uterine cervixCancer, 2003
- CYFRA 21-1 determination in patients with esophageal squamous cell carcinomaCancer, 2000
- Serum concentrations of squamous-cell carcinoma antigen and tissue polypeptide antigen in the follow-up of patients with vulvar cancerInternational Journal of Cancer, 1999
- TPA, TATI, CEA, AFP, β-HCG, PSA, SCC, and CA 19-9 for Monitoring Transitional Cell Carcinoma of the BladderAmerican Journal of Clinical Oncology, 1996
- Serum tumor markers in non-small cell lung cancer. A comparative analysisCancer, 1994
- Serum squamous cell carcinoma antigen levels in invasive squamous vulvar cancerJournal of Surgical Oncology, 1992
- Squamous cell carcinoma antigen is a new member of the serine protease inhibitorsBiochemical and Biophysical Research Communications, 1991
- Significance of serum SCC antigen as a tumor marker in patients with squamous cell carcinoma of the vulvaGynecologic Oncology, 1989
- Serum squamous cell carcinoma antigen levels in patients with invasive squamous vulvar and vaginal cancer: A preliminary reportGynecologic Oncology, 1989
- Radioimmunoassay for tumor antigen of human cervical squamous cell carcinomaCancer, 1977